Clinical Trial Update: Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 safety study of cetuximab in combination with cisplatin and vinorelbine for advanced non-small cell lung cancer has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Navelbine (vinorelbine)
• Platinol (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lung Neoplasms, Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-10